Abstract:Aims Vascular calcification (VC) predicts the morbidity and mortality in cardiovascular diseases. Vascular smooth muscle cells (VSMCs) osteogenic transdifferentiation is the crucial pathological basis for VC. To date, the molecular pathogenesis is still largely unclear. Notably, C5a-C5aR1 contributes to the development of cardiovascular diseases, and it's closely related to physiological bone mineralization which is similar to VSMCs osteogenic transdifferentiation. However, the role and underlying mechanisms of C5a-C5aR1 in VC remain unexplored. Methods and Results A cross-sectional clinical study was utilized to examine the association between C5a and VC. Chronic kidney diseases mice and calcifying VSMCs models were established to investigate the effect of C5a-C5aR1 in VC, evaluated by changes in calcium deposition and osteogenic markers. The cross-sectional study identified that high level of C5a was associated with increased risk of VC. C5a dose-responsively accelerated VSMCs osteogenic transdifferentiation accompanying with increased the expression of C5aR1. Meanwhile, the antagonists of C5aR1, PMX 53, reduced calcium deposition and osteogenic transdifferentiation both in vivo and in vitro. Mechanistically, C5a-C5aR1 induced endoplasmic reticulum stress and then activated PERK-eIF2α-ATF4 pathway to accelerated VSMCs osteogenic transdifferentiation. In addition, cAMP-response element-binding protein 3-like 1 (CREB3L1) was a key downstream mediator of PERK-eIF2α-ATF4 pathway which accelerated VSMCs osteogenic transdifferentiation by promoting the expression of COL1α1. Conclusions High level of C5a was associated with increased risk of VC, and it accelerated VC by activating the receptor C5aR1. PERK-eIF2α-ATF4-CREB3L1 pathway of endoplasmic reticulum stress was activated by C5a-C5aR1, hence promoting VSMCs osteogenic transdifferentiation. Targeting C5 or C5aR1 may be an appealing therapeutic target for VC.

Endoplasmic Reticulum Stress and Pathogenesis of Vascular Calcification

The Role of Extracellular Vesicles in Vascular Calcification in Chronic Kidney Disease

Endoplasmic Reticulum Stress-Mediated Apoptosis is Activated in Vascular Calcification.

Vascular calcification: Molecular mechanisms and therapeutic interventions

Role of endothelial cells in vascular calcification

Endoplasmic Reticulum Stress: a Novel Mechanism and Therapeutic Target for Cardiovascular Diseases

Endoplasmic Reticulum Stress: A Key Regulator of Cardiovascular Disease

C5a-C5aR1 induces endoplasmic reticulum stress to accelerate vascular calcification via PERK-eIF2α-ATF4-CREB3L1 pathway

Endothelial-to-mesenchymal transition: New insights into vascular calcification

Exosomes, the Message Transporters in Vascular Calcification

Vascular Calcification—New Insights into Its Mechanism

Contributions of the Endothelium to Vascular Calcification

The role of mitochondria in vascular calcification

Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases

Endoplasmic reticulum stress in diseases

A Narrative Review of Exosomes in Vascular Calcification

Vascular calcification: from the perspective of crosstalk

[New Research Advances in Relationship of Endoplasmic Reticulum Stress and Cardiovascular Diseases].

Roles and Therapeutic Implications of Endoplasmic Reticulum Stress and Oxidative Stress in Cardiovascular Diseases

Endoplasmic Reticulum Stress-Mediated Apoptosis Contributing to High Glucose-Induced Vascular Smooth Muscle Cell Calcification

Endoplasmic reticulum stress-mediated cell death in cardiovascular disease